Cardiovascular  ||| S:0 E:15 ||| JJ
performance  ||| S:15 E:27 ||| NN
assessed  ||| S:27 E:36 ||| VBN
with  ||| S:36 E:41 ||| IN
exercise  ||| S:41 E:50 ||| NN
testing  ||| S:50 E:58 ||| NN
Since  ||| S:58 E:64 ||| IN
the  ||| S:64 E:68 ||| DT
first  ||| S:68 E:74 ||| JJ
exercise  ||| S:74 E:83 ||| NN
electrocardiography  ||| S:83 E:103 ||| NNS
was  ||| S:103 E:107 ||| VBD
recorded  ||| S:107 E:116 ||| VBN
in  ||| S:116 E:119 ||| IN
1908 ||| S:119 E:123 ||| CD
,  ||| S:123 E:125 ||| ,
it  ||| S:125 E:128 ||| PRP
has  ||| S:128 E:132 ||| VBZ
been  ||| S:132 E:137 ||| VBN
in  ||| S:137 E:140 ||| IN
widespread  ||| S:140 E:151 ||| JJ
clinical  ||| S:151 E:160 ||| JJ
use  ||| S:160 E:164 ||| NN
for  ||| S:164 E:168 ||| IN
more  ||| S:168 E:173 ||| JJR
than  ||| S:173 E:178 ||| IN
100  ||| S:178 E:182 ||| CD
years ||| S:182 E:187 ||| NNS
.  ||| S:187 E:189 ||| .
Exercise  ||| S:189 E:198 ||| NN
testing  ||| S:198 E:206 ||| NN
can  ||| S:206 E:210 ||| MD
be  ||| S:210 E:213 ||| VB
performed  ||| S:213 E:223 ||| VBN
easily  ||| S:223 E:230 ||| RB
and  ||| S:230 E:234 ||| CC
noninvasively  ||| S:234 E:248 ||| NNS
and  ||| S:248 E:252 ||| CC
is  ||| S:252 E:255 ||| VBZ
relatively  ||| S:255 E:266 ||| RB
inexpensive ||| S:266 E:277 ||| JJ
.  ||| S:277 E:279 ||| .
This  ||| S:279 E:284 ||| DT
testing  ||| S:284 E:292 ||| NN
is  ||| S:292 E:295 ||| VBZ
generally  ||| S:295 E:305 ||| RB
safe  ||| S:305 E:310 ||| JJ
but  ||| S:310 E:314 ||| CC
myocardial  ||| S:314 E:325 ||| JJ
infarction  ||| S:325 E:336 ||| NN
and  ||| S:336 E:340 ||| CC
death  ||| S:340 E:346 ||| NN
occur  ||| S:346 E:352 ||| VBP
rarely ||| S:352 E:358 ||| RB
.  ||| S:358 E:360 ||| .
The  ||| S:360 E:364 ||| DT
Japanese  ||| S:364 E:373 ||| JJ
Circulation  ||| S:373 E:385 ||| NNP
Society  ||| S:385 E:393 ||| NNP
describes  ||| S:393 E:403 ||| VBZ
the  ||| S:403 E:407 ||| DT
wide  ||| S:407 E:412 ||| JJ
applications  ||| S:412 E:425 ||| NNS
of  ||| S:425 E:428 ||| IN
exercise  ||| S:428 E:437 ||| NN
testing  ||| S:437 E:445 ||| NN
in  ||| S:445 E:448 ||| IN
the  ||| S:448 E:452 ||| DT
guidelines ||| S:452 E:462 ||| NNS
.  ||| S:462 E:464 ||| .
The  ||| S:464 E:468 ||| DT
guideline  ||| S:468 E:478 ||| NN
for  ||| S:478 E:482 ||| IN
ischemic  ||| S:482 E:491 ||| JJ
heart  ||| S:491 E:497 ||| NN
disease  ||| S:497 E:505 ||| NN
prioritizes  ||| S:505 E:517 ||| NNS
exercise  ||| S:517 E:526 ||| VBP
testing  ||| S:526 E:534 ||| VBG
for  ||| S:534 E:538 ||| IN
the  ||| S:538 E:542 ||| DT
diagnosis  ||| S:542 E:552 ||| NN
of  ||| S:552 E:555 ||| IN
stable  ||| S:555 E:562 ||| JJ
angina  ||| S:562 E:569 ||| JJ
pectoris ||| S:569 E:577 ||| NN
.  ||| S:577 E:579 ||| .
Although  ||| S:579 E:588 ||| IN
the  ||| S:588 E:592 ||| DT
sensitivity  ||| S:592 E:604 ||| NN
and  ||| S:604 E:608 ||| CC
specificity  ||| S:608 E:620 ||| NNS
are  ||| S:620 E:624 ||| VBP
not  ||| S:624 E:628 ||| RB
as  ||| S:628 E:631 ||| IN
high  ||| S:631 E:636 ||| JJ
as  ||| S:636 E:639 ||| IN
other  ||| S:639 E:645 ||| JJ
noninvasive  ||| S:645 E:657 ||| JJ
testing  ||| S:657 E:665 ||| NN
( ||| S:665 E:666 ||| -LRB-
i.e. ||| S:666 E:670 ||| FW
,  ||| S:670 E:672 ||| ,
stress  ||| S:672 E:679 ||| FW
single-photon  ||| S:679 E:693 ||| FW
emission  ||| S:693 E:702 ||| FW
computed  ||| S:702 E:711 ||| FW
tomography ||| S:711 E:721 ||| FW
,  ||| S:721 E:723 ||| ,
computed  ||| S:723 E:732 ||| JJ
tomography  ||| S:732 E:743 ||| NN
and  ||| S:743 E:747 ||| CC
MRI ||| S:747 E:750 ||| NNP
) ||| S:750 E:751 ||| -RRB-
,  ||| S:751 E:753 ||| ,
exercise  ||| S:753 E:762 ||| NN
testing  ||| S:762 E:770 ||| NN
can  ||| S:770 E:774 ||| MD
also  ||| S:774 E:779 ||| RB
assess  ||| S:779 E:786 ||| VB
the  ||| S:786 E:790 ||| DT
severity  ||| S:790 E:799 ||| NN
and  ||| S:799 E:803 ||| CC
prognosis  ||| S:803 E:813 ||| NN
of  ||| S:813 E:816 ||| IN
the  ||| S:816 E:820 ||| DT
disease ||| S:820 E:827 ||| NN
.  ||| S:827 E:829 ||| .
Cardiac  ||| S:829 E:837 ||| JJ
rehabilitation  ||| S:837 E:852 ||| NN
is  ||| S:852 E:855 ||| VBZ
a  ||| S:855 E:857 ||| DT
useful  ||| S:857 E:864 ||| JJ
tool  ||| S:864 E:869 ||| NN
to  ||| S:869 E:872 ||| TO
improve  ||| S:872 E:880 ||| VB
the  ||| S:880 E:884 ||| DT
prognosis  ||| S:884 E:894 ||| NN
of  ||| S:894 E:897 ||| IN
patients  ||| S:897 E:906 ||| NNS
with  ||| S:906 E:911 ||| IN
myocardial  ||| S:911 E:922 ||| JJ
infarction ||| S:922 E:932 ||| NN
.  ||| S:932 E:934 ||| .
Exercise  ||| S:934 E:943 ||| NN
therapy  ||| S:943 E:951 ||| NN
is  ||| S:951 E:954 ||| VBZ
a  ||| S:954 E:956 ||| DT
main  ||| S:956 E:961 ||| JJ
component  ||| S:961 E:971 ||| NN
of  ||| S:971 E:974 ||| IN
cardiac  ||| S:974 E:982 ||| JJ
rehabilitation ||| S:982 E:996 ||| NN
,  ||| S:996 E:998 ||| ,
and  ||| S:998 E:1002 ||| CC
exercise  ||| S:1002 E:1011 ||| NN
testing  ||| S:1011 E:1019 ||| NN
is  ||| S:1019 E:1022 ||| VBZ
indispensable  ||| S:1022 E:1036 ||| VBN
for  ||| S:1036 E:1040 ||| IN
prescribing  ||| S:1040 E:1052 ||| JJ
exercise  ||| S:1052 E:1061 ||| NN
therapy ||| S:1061 E:1068 ||| NN
.  ||| S:1068 E:1070 ||| .
Exercise  ||| S:1070 E:1079 ||| NN
capacity  ||| S:1079 E:1088 ||| NN
is  ||| S:1088 E:1091 ||| VBZ
an  ||| S:1091 E:1094 ||| DT
important  ||| S:1094 E:1104 ||| JJ
prognostic  ||| S:1104 E:1115 ||| JJ
factor  ||| S:1115 E:1122 ||| NN
in  ||| S:1122 E:1125 ||| IN
patients  ||| S:1125 E:1134 ||| NNS
with  ||| S:1134 E:1139 ||| IN
heart  ||| S:1139 E:1145 ||| NN
failure ||| S:1145 E:1152 ||| NN
.  ||| S:1152 E:1154 ||| .
The  ||| S:1154 E:1158 ||| DT
guideline  ||| S:1158 E:1168 ||| NN
for  ||| S:1168 E:1172 ||| IN
the  ||| S:1172 E:1176 ||| DT
diagnosis  ||| S:1176 E:1186 ||| NN
of  ||| S:1186 E:1189 ||| IN
chronic  ||| S:1189 E:1197 ||| JJ
heart  ||| S:1197 E:1203 ||| NN
failure  ||| S:1203 E:1211 ||| NN
recommends  ||| S:1211 E:1222 ||| VBZ
cardiopulmonary  ||| S:1222 E:1238 ||| JJ
exercise  ||| S:1238 E:1247 ||| NN
testing  ||| S:1247 E:1255 ||| NN
to  ||| S:1255 E:1258 ||| TO
evaluate  ||| S:1258 E:1267 ||| VB
exercise  ||| S:1267 E:1276 ||| NN
capacity ||| S:1276 E:1284 ||| NN
.  ||| S:1284 E:1286 ||| .
